NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuroFlow

NeuroFlow

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.neuroflow.com/

Last Round

VC Round

Sep 6, 2023

Total Funding Raised

$56.43M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NeuroFlow is a healthcare technology company that provides a digital platform to integrate mental health programs with measurement-based care and consumer engagement for health systems, payers, and government entities.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Patient Engagement, Healthcare Analytics, Vertical SaaS, Telemedicine

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

behavioral health integrationintegrated behavioral healthcare coordinationmeasurement-based carepopulation health managementvalue-based caremental health screeningclinical workflow automationbehavioral health softwaredigital health platformbehavioral health techrisk stratificationEHR integrationmental health triagetelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroFlow Comps

Public and private peers based on sector, stage, and business model.

NeuroFlow comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuroFlow Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 6, 2023
GrantFeb 15, 2023
Series COct 12, 2022
Series BJan 12, 2021
GrantApr 1, 2020
Series A
Dec 16, 2019

Key People

Founding team and executive leadership

Christopher Molaro

CEO

Executive Team

Pete Tantillo

Chief Financial Officer

Executive Team

Robert Capobianco

Chief Operating Officer

Executive Team

NeuroFlow Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Requires Public Trust security clearance for certain roles.

  • Feb 8, 2026

    Added Centene Corp., a healthcare enterprise, as a customer.

NeuroFlow Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroFlow Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroFlow's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range178
Year Founded2016
Last FundingSep 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.